Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The nuclear division cycle 80 (Ndc80) complex is a heterotetrameric protein complex that plays an important role in cell mitosis. Abnormal expression of the Ndc80 complex causes chromosomal abnormalities, leading to genomic instability, which is a major factor in all tumorigenesis.
Structure and Function of the Ndc80 Complex
The Ndc80 complex is a heterotetrameric protein complex composed of Ndc80 (nuclear division cycle 80), Nuf2 (ndc80 kinetochore complex component), Spc24 (spindle pole body component 24 homolog) and Spc25 (spindle pole body component 25 homolog). It is 57 nm long and has a dumbbell shape. Ndc80 and Nuf2, Spc24 and Spc25 form two heterodimeric spherical domains, respectively, which are separated by a rod-like structure formed by coiled coils and connected by a tetramerization domain. The circular secondary structure in the coiled-coil domain forms a kink, which allows the molecule to bend and form a protein-protein action platform that facilitates interaction with the microtubule.
The Ndc80 complex can be bundled into a microtubule mesh to create an arrow-like appearance that helps bridge the kinetochore with the microtube. During cell division, the microtubule-based spindle is ligated with paired sister chromatids, captured and arranged in the middle of the cell. The kinetochore assembled on the sister chromatid interacts with the spindle microtubule to form a kinetochore-microtubule attachment. Kinesthetic - Microtubules must be strong enough to take advantage of the forces generated by microtubule dynamics to ensure chromosome motility and thus move toward the cell poles. The Ndc80 complex plays an important role in the formation and maintenance of robust kinetochore-particle attachments and is essential in the spindle checkpoint signaling pathway. Abnormal expression of Ndc80 complex causes microtubule-associated protein imbalance, microtubule dynamics disruption, and mitotic chromosome segregation abnormalities, leading to the formation of aneuploid cells, which is one of the characteristics of tumorigenesis. Therefore, there is a close relationship between the components of the Ndc80 complex and the tumor.
Figure 1. Model of the Ndc80 complex bridging two Dam1 complex rings, separated by 33 nm. (Kim, J. O., et al. 2017)
Ndc80 Complex and Tumor
A liver cancer-related study showed that the expression of Ndc80 mRNA in tumor tissues of 47 patients with liver cancer was higher than that in adjacent normal tissues. Ndc80 gene silencing by lentiviral transfection with Ndc80-siRNA inhibited the proliferation of SMMC-7721 hepatoma cell line cultured in vitro. The induction of apoptosis was initiated, demonstrating that Ndc80 induces hepatocarcinogenesis mainly through its pro-augmentation and anti-apoptotic effects. In osteosarcoma, 84.6% of tumor tissues expressed Ndc80 mRNA higher than adjacent normal tissues. Its expression level is related to tumor TNM stage, distant metastasis, etc., and Ndc80 is an independent prognostic indicator.
Xing et al. found that the expression of Ndc80 protein in colon cancer cell lines such as CACO2, HCT8, HCT116 and SW480 was higher than that in normal intestinal epithelial NCM460 cell line. After transfection of the Ndc80 gene, cell proliferation was significantly accelerated and showed a stronger metastatic potential. Compared with 76 mitotic spindle checkpoint genes in 10 breast cancer tissues and 5 normal breast tissues, Ndc80 expression was significantly up-regulated in breast cancer tissues with high invasive grade, 10 times higher than normal breast tissue, and 71. 4 % of benign breast tumors also have high expression of Ndc80, but only 3 times higher than normal breast tissue, which proves that Ndc80 is an effective indicator for judging the malignant transformation of breast lesions.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.